| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:10:01 UTC |
|---|
| Update date | 2025-11-18 23:34:25 UTC |
|---|
| Primary ID | FDB012158 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Chemical Information |
|---|
| FooDB Name | Serotonin |
|---|
| Description | Serotonin, also known as enteramine or 5-HT, belongs to the class of organic compounds known as serotonins. Serotonins are compounds containing a serotonin moiety, which consists of an indole that bears an aminoethyl a position 2 and a hydroxyl group at position 5. Serotonin is a very strong basic compound (based on its pKa). Serotonin exists in all living organisms, ranging from bacteria to humans. Serotonin is found, on average, in the highest concentration within a few different foods, such as sea-buckthornberries, common walnuts, and oats and in a lower concentration in green beans, red bell peppers, and swiss chards. Serotonin has also been detected, but not quantified in, several different foods, such as grapes, cocoa beans, pepper (c. frutescens), avocado, and common pea. This could make serotonin a potential biomarker for the consumption of these foods. Serotonin, with regard to humans, has been found to be associated with several diseases such as eosinophilic esophagitis, schizophrenia, parkinson's disease, and hypothyroidism; serotonin has also been linked to the inborn metabolic disorder aromatic l-amino acid decarboxylase deficiency. |
|---|
| CAS Number | 50-67-9 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| 3-(2-Aminoethyl)-1H-indol-5-ol | ChEBI | | 5-HT | ChEBI | | 5-Hydroxytryptamine | ChEBI | | Enteramine | ChEBI | | Serotonine | ChEBI | | Thrombocytin | ChEBI | | Thrombotonin | ChEBI | | Hippophaine | HMDB | | Hydroxytryptamine | HMDB | | 5 Hydroxytryptamine | HMDB | | 3-(2-Aminoethyl)indol-5-ol | HMDB | | 3-(b-Aminoethyl)-5-hydroxyindole | HMDB | | 5-HTA | HMDB | | 5-Hydroxy-3-(b-aminoethyl)indole | HMDB | | 5-Hydroxy-tryptamine | HMDB | | 5-Hydroxyltryptamine | HMDB | | 5-Hydroxytriptamine | HMDB | | Antemovis | HMDB | | DS Substance | HMDB | | Enteramin | HMDB | | 3-(2-Aminoethyl)-1H-indol-5-ol, 9CI | db_source | | 3-(2-Aminoethyl)-5-hydroxyindole | db_source | | 5HT | db_source | | Anthemovister | db_source | | DS substance | HMDB | | Serotonin | db_source |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C10H12N2O |
|---|
| IUPAC name | 3-(2-aminoethyl)-1H-indol-5-ol |
|---|
| InChI Identifier | InChI=1S/C10H12N2O/c11-4-3-7-6-12-10-2-1-8(13)5-9(7)10/h1-2,5-6,12-13H,3-4,11H2 |
|---|
| InChI Key | QZAYGJVTTNCVMB-UHFFFAOYSA-N |
|---|
| Isomeric SMILES | NCCC1=CNC2=CC=C(O)C=C12 |
|---|
| Average Molecular Weight | 176.2151 |
|---|
| Monoisotopic Molecular Weight | 176.094963016 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as serotonins. Serotonins are compounds containing a serotonin moiety, which consists of an indole that bears an aminoethyl a position 2 and a hydroxyl group at position 5. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Indoles and derivatives |
|---|
| Sub Class | Tryptamines and derivatives |
|---|
| Direct Parent | Serotonins |
|---|
| Alternative Parents | |
|---|
| Substituents | - Serotonin
- 3-alkylindole
- Hydroxyindole
- Indole
- 2-arylethylamine
- 1-hydroxy-2-unsubstituted benzenoid
- Aralkylamine
- Substituted pyrrole
- Benzenoid
- Pyrrole
- Heteroaromatic compound
- Azacycle
- Hydrocarbon derivative
- Organopnictogen compound
- Amine
- Organic oxygen compound
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Primary aliphatic amine
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
|
| Physiological effect | Health effect: |
|---|
| Disposition | Route of exposure: Source: Biological location: |
|---|
| Role | Industrial application: |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Solid | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 68.16%; H 6.86%; N 15.90%; O 9.08% | DFC |
|---|
| Melting Point | 167.5 oC | |
|---|
| Boiling Point | Not Available | |
|---|
| Experimental Water Solubility | 20 mg/mL at 27 oC | HORN,AS (1981) |
|---|
| Experimental logP | 0.21 | HANSCH,C ET AL. (1995) |
|---|
| Experimental pKa | pKa3 15 (20°) | DFC |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | Not Available | |
|---|
| Optical Rotation | Not Available | |
|---|
| Spectroscopic UV Data | Not Available | |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| GC-MS | Serotonin, 5 TMS, GC-MS Spectrum | splash10-00di-1900000000-461c2a1f67418e6b5d6a | Spectrum | | GC-MS | Serotonin, 5 TMS, GC-MS Spectrum | splash10-00di-1900000000-2286e87324e9f4a78cb4 | Spectrum | | GC-MS | Serotonin, non-derivatized, GC-MS Spectrum | splash10-00di-1900000000-927b865023cbba872101 | Spectrum | | GC-MS | Serotonin, non-derivatized, GC-MS Spectrum | splash10-00di-1910000000-02c17b4cd3336a8bf9b1 | Spectrum | | GC-MS | Serotonin, 5 TMS, GC-MS Spectrum | splash10-00di-8900000000-4b838943ace80c8b7734 | Spectrum | | GC-MS | Serotonin, 5 TMS, GC-MS Spectrum | splash10-00di-6900000000-a7dd5c569cf4d085d244 | Spectrum | | GC-MS | Serotonin, 4 TMS, GC-MS Spectrum | splash10-00di-0900000000-2346e553f96cb980c8fc | Spectrum | | GC-MS | Serotonin, 3 TMS, GC-MS Spectrum | splash10-00di-1900000000-01fbd5196188d4e0f21c | Spectrum | | GC-MS | Serotonin, non-derivatized, GC-MS Spectrum | splash10-0002-9800000000-9ce9fb2286c3b7ea7719 | Spectrum | | GC-MS | Serotonin, non-derivatized, GC-MS Spectrum | splash10-00di-1900000000-461c2a1f67418e6b5d6a | Spectrum | | GC-MS | Serotonin, non-derivatized, GC-MS Spectrum | splash10-00di-1900000000-2286e87324e9f4a78cb4 | Spectrum | | GC-MS | Serotonin, non-derivatized, GC-MS Spectrum | splash10-00di-1900000000-927b865023cbba872101 | Spectrum | | GC-MS | Serotonin, non-derivatized, GC-MS Spectrum | splash10-00di-1910000000-02c17b4cd3336a8bf9b1 | Spectrum | | GC-MS | Serotonin, non-derivatized, GC-MS Spectrum | splash10-00di-8900000000-4b838943ace80c8b7734 | Spectrum | | GC-MS | Serotonin, non-derivatized, GC-MS Spectrum | splash10-00di-6900000000-a7dd5c569cf4d085d244 | Spectrum | | GC-MS | Serotonin, non-derivatized, GC-MS Spectrum | splash10-00di-0900000000-2346e553f96cb980c8fc | Spectrum | | GC-MS | Serotonin, non-derivatized, GC-MS Spectrum | splash10-00di-1900000000-01fbd5196188d4e0f21c | Spectrum | | Predicted GC-MS | Serotonin, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-001j-6900000000-95a89ff8a3b12e7e8e25 | Spectrum | | Predicted GC-MS | Serotonin, 1 TMS, Predicted GC-MS Spectrum - 70eV, Positive | splash10-001i-9450000000-52e0b628b7795c643362 | Spectrum | | Predicted GC-MS | Serotonin, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Serotonin, TMS_1_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Serotonin, TMS_1_3, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Serotonin, TBDMS_1_1, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Serotonin, TBDMS_1_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Serotonin, TBDMS_1_3, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated) | splash10-0a4i-0900000000-6acaf73bcd452e24b886 | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated) | splash10-0aor-0900000000-259227b20b82e6362059 | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated) | splash10-02e9-5900000000-2f58fbed270523182158 | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - EI-B (HITACHI M-80) , Positive | splash10-0002-9800000000-abcd0769bb17d07b3e38 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive | splash10-03di-0900000000-bf65d809200ea387ebf5 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive | splash10-03di-0900000000-8a171ac4fdc0474f7f48 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive | splash10-03xr-0900000000-a0b7d8a671909c6f4ad1 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive | splash10-014i-1900000000-fa80d05236eabbafd678 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive | splash10-014i-4900000000-4e2e322d56fc9ee00edd | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Positive | splash10-004i-0900000000-c79f0b03a8dc1da0a10a | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) 30V, Positive | splash10-03fr-0900000000-9cb056cd56bae76589d0 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Linear Ion Trap , negative | splash10-03di-1900000000-d64210214a1b3766ff6e | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , positive | splash10-03di-0900000000-08840bc938c367dacbb2 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , positive | splash10-03yi-0900000000-858936972fd87c0c0b14 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , positive | splash10-0159-4900000000-a8fc7dff385a4f51b88a | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , positive | splash10-00p0-9400000000-7e4063d2b516ae59df84 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ , positive | splash10-03di-0900000000-bf65d809200ea387ebf5 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ , positive | splash10-03di-0900000000-8a171ac4fdc0474f7f48 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ , positive | splash10-03xr-0900000000-a0b7d8a671909c6f4ad1 | 2017-09-14 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-01t9-0900000000-a4e556450f24165aed15 | 2017-06-28 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03di-0900000000-657c360c251ec5745d1f | 2017-06-28 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-01qc-2900000000-397a6873ea727da9cc8f | 2017-06-28 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-004i-0900000000-253552852dde8abefca0 | 2017-06-28 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-004i-0900000000-5dd492dfc2d781e72254 | 2017-06-28 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-053r-1900000000-bed3bfffbc9cca506281 | 2017-06-28 | View Spectrum |
|
|---|
| NMR | | Type | Description | | View |
|---|
| 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | | Spectrum | | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | | Spectrum |
|
|---|
| External Links |
|---|
| ChemSpider ID | 5013 |
|---|
| ChEMBL ID | CHEMBL39 |
|---|
| KEGG Compound ID | C00780 |
|---|
| Pubchem Compound ID | 5202 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | Not Available |
|---|
| Phenol-Explorer ID | Not Available |
|---|
| DrugBank ID | Not Available |
|---|
| HMDB ID | HMDB00259 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | HDV23-B:HDV23-B |
|---|
| EAFUS ID | Not Available |
|---|
| Dr. Duke ID | HIPPOPHAIN|HIPPOPHAINUM|5-HYDROXYTRYPTAMINE|SEROTONIN|SEROTIN |
|---|
| BIGG ID | 35982 |
|---|
| KNApSAcK ID | C00001429 |
|---|
| HET ID | SRO |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | Not Available |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Serotonin |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Abortifacient | 50691 | An agent that induces abortion, disrupting pregnancy by blocking progesterone or causing uterine contractions. Therapeutically, it's used to terminate early pregnancies, manage ectopic pregnancies, or treat miscarriages. Key medical uses include medical abortion, pregnancy termination, and menstrual regulation. | DUKE | | Allergenic | 50904 | A substance that triggers an immune response, causing allergic reactions. Its biological role is to stimulate the immune system, but it has no therapeutic applications. Key medical uses include diagnosing allergies and developing immunotherapies to desensitize patients to specific allergens, reducing the risk of severe reactions. | DUKE | | Analgesic | 35480 | An agent that relieves pain by reducing or blocking pain signals in the brain, commonly used to manage acute or chronic pain, inflammation, and fever, with therapeutic applications in surgery, injury, and disease treatment. | DUKE | | Anti-aggregant | | An agent that prevents platelet aggregation, reducing blood clot formation. Its biological role is to inhibit platelet activation, and its therapeutic applications include preventing thrombosis and stroke. Key medical uses include treating cardiovascular diseases, such as myocardial infarction and atrial fibrillation, and managing conditions that increase the risk of blood clots. | DUKE | | Anti-Alzheimeran | 52217 | An agent that inhibits the progression of Alzheimer's disease, reducing beta-amyloid plaque formation and neuroinflammation. Therapeutically, it improves cognitive function and memory, commonly used in managing mild to moderate Alzheimer's disease and other neurodegenerative disorders. | DUKE | | Anti cholinesterase | 37733 | An agent that inhibits acetylcholinesterase, increasing acetylcholine levels, and enhancing cholinergic transmission. Therapeutically, it's used to treat myasthenia gravis, glaucoma, and Alzheimer's disease, improving muscle strength, reducing eye pressure, and enhancing cognitive function. | DUKE | | Anti convulsant | 52217 | An agent that reduces or prevents seizures, commonly used in managing epilepsy, neuropathic pain, and mood disorders, by stabilizing abnormal electrical activity in the brain. | DUKE | | Anti depressant | 52217 | An agent that regulates mood, reducing symptoms of depression and anxiety by altering neurotransmitter levels in the brain, commonly used in managing depression, anxiety disorders, and other mood disorders. | DUKE | | Antidote | 50247 | An agent that counteracts a poison or toxin, neutralizing its harmful effects. It plays a biological role in reversing toxicity, and has therapeutic applications in treating poisoning, overdose, and envenomation. Key medical uses include emergency treatment for snake bites, drug overdose, and chemical exposure. | DUKE | | Anti endotoxic | 50247 | An agent that neutralizes or mitigates the effects of endotoxins, reducing inflammation and septic shock. Therapeutically, it is used to treat conditions such as sepsis, meningitis, and other endotoxin-mediated diseases, promoting immune system balance and preventing tissue damage. | DUKE | | Anti-gastric | | An antibody targeting gastric parietal cells, linked to autoimmune gastritis and pernicious anemia, used to diagnose and manage these conditions, helping to reduce stomach inflammation and improve nutrient absorption. | DUKE | | Anti gastrisecretogogic | | An agent that inhibits gastric acid secretion, reducing stomach acidity. Its biological role is to regulate digestive processes. Therapeutically, it's used to treat conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome, providing relief from heartburn, bloating, and abdominal pain. | DUKE | | Anti-mutilation | | An agent that prevents or reduces self-mutilation behaviors, commonly used in managing mental health disorders such as borderline personality disorder, autism, and schizophrenia, to reduce harm and improve patient well-being. | DUKE | | Anti-Parkinsonian | 48407 | An agent that alleviates symptoms of Parkinson's disease, enhancing dopamine levels and improving motor function, commonly used to manage tremors, rigidity, and bradykinesia in neurodegenerative disorders. | DUKE | | Anti-predatory | | A defense mechanism that prevents or deters predation, playing a biological role in survival. Therapeutically, it has applications in reducing stress and anxiety in prey animals. Key medical uses include animal welfare and conservation, where anti-predatory measures can help protect endangered species from predators. | DUKE | | Anti-reserpine | | An agent that counteracts the effects of reserpine, increasing neurotransmitter levels. Therapeutically, it's used to manage reserpine-induced side effects, such as depression, and has applications in treating Parkinson's disease, schizophrenia, and other neurological disorders. | DUKE | | Anti-scoliotic | 52217 | An agent that prevents or reduces the progression of scoliosis, a lateral curvature of the spine. It plays a biological role in maintaining spinal alignment and stability. Therapeutically, it is used to manage scoliosis, particularly in children and adolescents, to prevent deformity and promote proper spinal growth, reducing the need for surgical intervention. | DUKE | | Anti-Tourette's | 52217 | An agent that reduces tic symptoms, commonly used in managing Tourette's syndrome, with a biological role in regulating neurotransmitter imbalance, and therapeutic applications in reducing involuntary movements and vocalizations, with key medical uses including treatment of tic disorders and associated conditions. | DUKE | | Bronchoconstrictor | 50141 | An agent that narrows airway passages, used therapeutically to diagnose asthma or chronic obstructive pulmonary disease (COPD), and medically to treat conditions such as post-operative bronchospasm, or to reverse excessive bronchodilation. | DUKE | | Cancer preventive | 35610 | An agent that inhibits the development and progression of cancer, reducing tumor formation and growth. It plays a biological role in blocking carcinogenic pathways, and has therapeutic applications in chemoprevention. Key medical uses include reducing the risk of cancer in high-risk individuals and preventing cancer recurrence. | DUKE | | Cardiovascular | 38070 | A system that transports blood, oxygen, and nutrients throughout the body, playing a crucial role in overall health. Therapeutically, cardiovascular agents manage conditions like hypertension, heart failure, and atherosclerosis, with key medical uses including regulating blood pressure, preventing blood clots, and improving cardiac function. | DUKE | | Cerebrophilic | | A compound with high affinity for the brain, crossing the blood-brain barrier easily. Its biological role involves neuroprotection and neurotransmitter modulation. Therapeutically, it has applications in neurodegenerative diseases, such as Alzheimer's and Parkinson's. Key medical uses include treating cognitive impairment, neuroinflammation, and mood disorders, making it a potential agent for improving brain health and function. | DUKE | | Coagulant | | An agent that causes blood or another liquid to coagulate, playing a crucial biological role in wound healing and hemostasis. Therapeutically, coagulants are used to treat bleeding disorders, such as hemophilia, and to prevent excessive bleeding during surgery, with key medical uses including trauma treatment and transfusion medicine. | DUKE | | Euphoriant | | An agent that produces a feeling of euphoria, often used therapeutically to manage mood disorders, such as depression, and anxiety. It plays a biological role in stimulating the brain's reward system, releasing dopamine and endorphins. Key medical uses include treating addiction, chronic pain, and mental health conditions, promoting relaxation and well-being. | DUKE | | Hypertensive | | An agent that increases blood pressure, used therapeutically to treat hypotension (low blood pressure) and shock, and medically to manage conditions such as orthostatic hypotension and postural hypotension. | DUKE | | Insecticide | 24852 | An agent that kills or repels insects, used to control pests and prevent disease transmission. Therapeutically, insecticides have applications in public health and veterinary medicine, key medical uses include controlling insect-borne diseases such as malaria, typhus, and Lyme disease. | DUKE | | Myorelaxant | | An agent that reduces muscle contractility by blocking nerve impulses or decreasing motor end plate excitability, used therapeutically to relieve muscle spasms, tension, and pain, commonly in managing musculoskeletal disorders, anxiety, and insomnia. | DUKE | | Myostimulant | | An agent that stimulates an increase in the rhythm and amplitude of smooth muscle movement, playing a biological role in enhancing muscle contraction. Therapeutically, it is used to treat gastrointestinal disorders, such as constipation, and other conditions characterized by reduced muscle activity, like urinary retention. | DUKE | | Neurotransmitter | 25512 | A chemical messenger that transmits signals between neurons, regulating various physiological and psychological processes. Therapeutically, neurotransmitter modulators are used to treat conditions such as depression, anxiety, and Parkinson's disease, by altering neurotransmitter levels or activity to restore balance and alleviate symptoms. | DUKE | | Oxytocic | 36063 | A hormone that stimulates uterine contractions, playing a key role in childbirth and lactation. Therapeutically, it induces labor, controls postpartum bleeding, and promotes milk letdown. Medical uses include augmenting labor, treating postpartum hemorrhage, and assisting with breastfeeding. | DUKE | | Pesticide | 25944 | An agent that kills or repels pests, playing a biological role in controlling insect, weed, and fungal populations. Therapeutically, pesticides have limited applications, but some are used to treat ectoparasitic infestations, such as lice and scabies. Key medical uses include topical treatments for head lice and scabies, highlighting their role in managing parasitic infections. | DUKE | | Secretogogue | | A substance that stimulates secretion, playing a biological role in regulating hormone and enzyme release. Therapeutically, it has applications in treating conditions like hyposecretion and is used to manage digestive issues, respiratory problems, and endocrine disorders, promoting healthy secretion in various bodily systems. | DUKE | | Spasmogenic | | An agent that induces spasms, causing sudden involuntary muscular contractions. It plays a biological role in stimulating muscle activity. Therapeutically, it has applications in diagnosing and treating muscle disorders. Key medical uses include assessing muscle function and treating conditions like muscle atrophy, with potential applications in physical therapy and rehabilitation. | DUKE | | Succinic-dehydrogenase inhibitor | 23924 | An agent that blocks the activity of succinic dehydrogenase, an enzyme in the citric acid cycle. It has therapeutic applications in managing cancer, infectious diseases, and neurological disorders, with key medical uses including anti-cancer and anti-parasitic treatments. | DUKE | | Teratogenic | 50905 | An agent that causes abnormal fetal development, disrupting embryonic growth and leading to birth defects. Its biological role is associated with developmental toxicity, and it has no therapeutic applications. Key medical uses include serving as a warning for substances that pose risks during pregnancy, guiding prenatal care and medication management to prevent birth defects. | DUKE | | Ulcerogenic | | An agent that causes the production of ulcers, often used to study gastrointestinal disease mechanisms. Its biological role involves disrupting mucosal defense, leading to ulcer formation. Therapeutically, understanding ulcerogenic agents informs the development of anti-ulcer medications. Key medical uses include researching gastric ulcer pathogenesis and testing potential treatments for ulcer prevention and healing. | DUKE | | Vasoactive | | An agent that affects blood vessel diameter, regulating blood pressure and flow. It plays a biological role in maintaining cardiovascular homeostasis. Therapeutically, vasoactive agents are used to treat conditions like hypertension, heart failure, and shock, and have applications in managing bleeding and perfusion during surgery. | DUKE | | Vasoconstrictor | 50514 | An agent that narrows blood vessels, reducing blood flow. It plays a biological role in regulating blood pressure and is therapeutically used to treat conditions like hypotension, nasal congestion, and bleeding. Key medical uses include managing shock, reducing bleeding during surgery, and relieving migraine headaches. | DUKE |
|
|---|
| Enzymes | | Name | Gene Name | UniProt ID |
|---|
| Aromatic-L-amino-acid decarboxylase | DDC | P20711 | | Serotonin N-acetyltransferase | AANAT | Q16613 | | 5-hydroxytryptamine receptor 7 | HTR7 | P34969 | | 5-hydroxytryptamine receptor 1B | HTR1B | P28222 | | 5-hydroxytryptamine receptor 1A | HTR1A | P08908 | | 5-hydroxytryptamine receptor 3A | HTR3A | P46098 | | 5-hydroxytryptamine receptor 1D | HTR1D | P28221 | | 5-hydroxytryptamine receptor 4 | HTR4 | Q13639 | | 5-hydroxytryptamine receptor 1F | HTR1F | P30939 |
|
|---|
| Pathways | |
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | Not Available |
|---|
| Files |
|---|
| MSDS | show |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004). — Shinbo, Y., et al. 'KNApSAcK: a comprehensive species-metabolite relationship database.' Plant Metabolomics. Springer Berlin Heidelberg, 2006. 165-181. — Saxholt, E., et al. 'Danish food composition databank, revision 7.' Department of Nutrition, National Food Institute, Technical University of Denmark (2008).
|
|---|